Top compounds associated with response to CD19


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.024 0.6
mRNA tivozanib GDSC1000 pan-cancer AAC -0.069 0.09
mRNA tivozanib CTRPv2 pan-cancer AAC -0.054 0.2
mRNA tosedostat CTRPv2 pan-cancer AAC 0.025 0.5
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.1
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.019 0.6
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.011 0.7
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.058 0.2
mRNA triptolide CTRPv2 pan-cancer AAC -0.058 0.1
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.13 0.0005
Download CSV